Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page
- Check5 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a small update to the page metadata; no study data or eligibility criteria are affected.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new 'Sample Collection' item was added and the page revision updated to v3.5.4; the previous version v3.5.3 was removed.SummaryDifference0.2%

- Check49 days agoChange DetectedUpdates the ClinicalTrials.gov page’s displayed revision identifier (e.g., version v3.5.2 to v3.5.3), reflecting a site/software release rather than a change to the trial record.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded a new release entry on 2026-04-13 with Revision: v3.5.2, replacing the previous Revision: v3.5.0 dated 2026-04-08.SummaryDifference0.1%

- Check63 days agoChange DetectedStudy record dates were updated with new entries on 2026-04-08 and 2026-04-09, and older entries were removed on 2026-04-02 and 2026-04-03.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded updates dated 2026-04-02 and 2026-04-03, and removed updates dated 2026-03-26 and 2026-03-27.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.